Members of the transforming growth factor-b (TGF-b) family, including TGF-bs, activin and bone morphogenetic proteins (BMPs), are multifunctional proteins that regulate a wide variety of cellular responses, such as proliferation, differentiation, migration and apoptosis. TGF-b family signalling is mainly mediated by membranous serine/threonine kinase receptors and intracellular Smad proteins. This signalling is tightly regulated by various post-translational modifications including ubiquitination. Several E3 ubiquitin ligases play a crucial role in the recognition and ubiquitindependent degradation of TGF-b family receptors, Smad proteins and their interacted proteins to regulate positively and negatively TGF-b family signalling. In contrast, non-degradative ubiquitin modifications also regulate TGF-b family signalling. Recently, in addition to protein ubiquitination, deubiquitination by deubiquitinating enzymes has been reported to control TGF-b family signalling pathways. Interestingly, more recent studies suggest that TGF-b signalling is not only regulated via ubiquitination and/or deubiquitination, but also it relies on ubiquitination for its effect on other pathways. Thus, ubiquitin modifications play key roles in TGF-b family signal transduction and cross-talk between TGF-b family signalling and other signalling pathways. Here, we review the current understandings of the positive and negative regulatory mechanisms by ubiquitin modifications that control TGF-b family signalling.
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TGF-b Family Signalling by Smad Proteins
Transforming growth factor-b (TGF-b) is a member of TGF-b family that includes TGF-bs, activin and bone morphogenetic proteins (BMPs) (1) . Members of TGF-b family are pleiotropic proteins that regulate various biological responses, including proliferation, differentiation and apoptosis. The TGF-b family members bind to two distinct membranous serine/threonine kinase receptors, termed type II and type I (25) . Upon ligand stimulation, type II receptors and type I receptors form a hetero-tetramer complex. Then, the constitutively active type II receptors phosphorylate the GS domains of type I receptors, resulting in the activation of type I receptors (Fig. 1) . Intracellular signalling of TGF-b family is mainly mediated by Smad proteins. Activated type I receptor kinase phosphorylates receptor-regulated Smads (R-Smads) including Smad2 and Smad3 (TGF-b/activin-specific R-Smads) and Smad1, Smad5 and Smad8 (BMP-specific R-Smads), typically at a C-terminal SXS motif. Phosphorylated R-Smads in turn form a heteromeric complex with Smad4, a common Smad (Co-Smad), and translocate into the nucleus, where they regulate transcription of various target genes together with transcriptional factors, such as FoxH1, Mixer, Runxrelated proteins and E2F, as well as transcriptional co-activators (e.g. p300 and CBP) and co-repressors (e.g. c-Ski and SnoN) (6) . Inhibitory Smads (I-Smads), Smad6 and Smad7 that are induced by TGF-b family ligands in turn inhibit the TGF-b/ BMP signalling pathways, thus forming a negative feedback loop (710). While Smad7 inhibits both TGF-b and BMP signalling, Smad6 efficiently inhibits BMP signalling but only weakly TGF-b/activin signalling (1114).
transduction, transcriptional regulation, receptor down-regulation and endocytosis (15, 16) . Among the various functions of protein ubiquitination, the most characterized function is tagging for selective proteolysis by the 26S proteasome. Protein ubiquitination is catalysed by three kinds of enzymes, an ubiquitin-activating enzyme E1, an ubiquitin-conjugating enzyme E2 and an ubiquitin ligase E3, by which multiple ubiquitins are covalently added to substrates. Among three enzymes, E3 ubiquitin ligase is most crucial in the selective recognition of target proteins (17, 18) . The ubiquitinated substrates are recognized and degraded by the 26S proteasome after the polyubiquitin chain is processed off and recovered by deubiquitinating enzymes (DUBs). Frequently, genetic alterations and aberrations in the expression of E3 ubiquitin ligases result in various diseases such as cancer (19) .
It has been reported that ubiquitination is important in the vacuolar sorting process of endocytic and biosynthetic membrane proteins (20, 21) . In these processes, ubiquitin acts as a signal for endocytosis at the plasma membrane as well as a signal to sort cargo proteins into the multivesicular body at the endosome. This is a critical step to their transport to lysosomes, and DUBs remove ubiquitin from the cargo before its entry into the multivesicular body.
Classification of E3 Ubiquitin Ligases
E3 ubiquitin ligases can be classified into three major types based on domain structure and substrate recognition. The first class is N-end rule ubiquitin ligases such as Drosophila inhibitor of apoptosis protein (22, 23) . The second class is the Really Interesting New Gene (RING) family, and the third one is homologous to the E6-assosiated protein carboxyl terminus (HECT). The U-box-containing E3 ubiquitin ligase has been identified as a new class of E3 ubiquitin ligase. Because U-box forms a structure similar to that of a RING finger, U-box-containing E3 ubiquitin ligase is addressed as a member of RING/Ubox E3 ligase family in this review.
Smad Ubiquitin Regulatory Factors
Smad ubiquitin regulatory factor 1 (Smurf1) was originally identified as a HECT-type E3 ubiquitin ligase that interacts with BMP-specific R-Smads and regulates BMP signalling (24) (Fig. 1 ). Smurf2, a Smurf1-related E3 ubiquitin ligase, also interacts with Smad1/5 as well as with activated Smad2 and regulates TGF-b and BMP signalling (25, 26) (Fig. 1 ). Smurfs contain a protein kinase C conserved 2 (C2) domain at the N terminus, WW domains in the middle and a HECT domain at the C terminus (Fig. 2) . A C2 domain is required for membrane binding, WW domains for proteinprotein interaction and a HECT domain for ubiquitin protein ligation. Smurf1 interacts with the PY motif in linker region of Smad1 and Smad5 via its WW domains, and induces degradation of Smads (24) (Fig. 2) .
Modification of Smad proteins, particularly phosphorylation of the linker region of R-Smads, is crucial in the regulation of TGF-b family signalling by Smurfs. It has been reported that phosphorylation of the linker region of Smad1 enhances poly-ubiquitination and degradation of Smad1 (27) . In addition to enhancing poly-ubiquitination and degradation of Smad1, association of Smurf1 to Smad1 blocks interaction between Smad1 and the nuclear translocation factor Nup214, suggesting that linker phosphorylation-dependent Smurf1 binding results in Smad1 degradation or cytoplasmic retention. We demonstrated the possible molecular mechanism by which phosphorylation of R-Smad linker regions exerts these effects. They showed that Pin1, a peptidyl-prolyl cis-trans isomerase (PPIase), interacts with phosphorylated (S/T)P (p(S/T)P) motifs in the linker regions of Smad2 and Smad3, and enhances Smurf2-mediated ubiquitin-proteasomal degradation of Smad2 and Smad3 (28) .
Smurf1 and Smurf2 bind to not only R-Smads, but also Smad6 and Smad7, and induce the ubiquitindependent degradation of Smad6/7 and the interacted TGF-b family receptors (2931). Binding of Smurf1 and Smurf2 to Smad7 induces their nuclear export and recruitment to activated receptors, resulting in the ubiquitination-dependent degradation of the receptors-Smad7 complex. Smurf1 which contains nuclear export signal (NES) at the C terminus also binds to chromosomal region maintenance 1 (CRM1) in the nucleus, and induces the export of Smad7 from the nucleus to the cytoplasm (32) . Then, SmurfSmad7 complex localizes to the plasma membrane through C2 domain of Smurf1, and associates with activated type I receptors (33) .
It has been reported that the Smad7 N domain (Smad7N) is required for efficient blockade of TGFb signalling by Smad7 (11) , and Smad7N modulates the catalytic activity of the Smurf2 HECT domain by enhancing the interaction of Smurf2 with the UbcH7 E2 (34), suggesting that Smad7 both regulates Smurf2 activity by promoting E2 binding to its HECT domain and aids in recruiting Smurf2 to membrane receptors. In addition, Smurf2 associated with Smurf1 and ubiquitinated Smurf1 (35) . To note that not only Smad7, but also Smad2 plays crucial roles in regulating the Smurf activity (36) . After TGF-b stimulation, Smad2 forms a complex with Smurf2, and regulate the interaction between Smurf2 and transcriptional co-repressor SnoN. Subsequently, Smurf2 induces the ubiquitin-dependent degradation of SnoN (36) .
In
Because this interaction has been reported to inhibit catalytic activity of Smurf2 by interfering with ubiquitin thioester formation, and stabilized Smurf2 levels, auto-inhibition of the Smurf2 HECT domain by the C2 domain maintains the steady-state levels of this E3 ubiquitin ligase and can be relieved by adaptormediated substrate targeting (37).
Other HECT-type E3 Ubiquitin Ligases
In addition to Smurfs, E3 ubiqutin ligases that share a characteristic domain organization with Smurf proteins also mediate signalling by members of TGF-b family. Among the ligases, WWP1/TGIF-interacting ubiquitin ligase 1 (Tiul1) and neural precursor cellsexpressed developmentally down-regulated 4 (Nedd4)-2 have been identified as Smad7-binding proteins by yeast two-hybrid screening (38, 39) . In cultured cells, WWP1 and Nedd4-2 bind to the TGF-b type I receptor (TbR-I) through Smad7, followed by induction of ubiquitination and degradation of TbR-I. Binding of WWP1 and Nedd4-2 to Smad7 also enhance ubiquitination of Smad4 (40) . Moreover, Nedd4-2 targeted activated Smad2/3 (41). Interestingly, although both Nedd4-2 and WWP1 enhance the ubiquitin-dependent degradation of Smad2 in the presence of TGF-b signalling, ubiquitination of Smad2 by WWP1, but not by Nedd4-2, may require TGIF and other factors involved in TGF-b signalling (42).
RNF111/Arkadia
RNF111/Arkadia was originally identified as a protein essential for the induction of mammalian nodes by enhancing nodal signalling during embryonic development (43, 44) . Arkadia contains a RING-finger domain at its C-terminus required for ubiquitin protein ligation, and associates with Smad7 to induce ubiquitination and proteasomal degradation of Smad7 (45) . Interestingly, in contrast to the Smurf proteins, Arkadia does not bind to TbR-I and fails to induce its degradation. In addition to Smad7, Arkadia Regulation of TGF-b family signalling by ubiquitination and deubiquitination interacts with various negative regulators of TGF-b signalling including c-Ski and SnoN to up-regulate TGF-b signalling (4648) (Fig. 1) . Some binding partners of Arkadia have been reported to act as regulator of Arkadia function. Axin, a regulator of Wnt signalling, functions as a scaffold protein to promote Smad7 degradation by Arkadia (49) . RB1-inducible coiledcoil 1 (RB1CC1), also termed focal adhesion kinase interacting protein of 200kD (FIP200), enhances TGF-b signalling by acting as a co-factor of Arkadia (50) .
So far, little is known about the molecular mechanisms that control the activity of Arkadia. Xia et al. have recently shown that the four and a half LIMonly protein 2 (FHL2) binds to Arkadia and synergistically cooperates with Arkadia to activate Smad3/ Smad4-dependent transcription (51) . Interestingly, Arkadia is ubiquitinated via K63-and K27-linked poly-ubiquitination partly by auto-ubiquitination. FHL2 increases the half-life of Arkadia through inhibition of its ubiquitination.
In addition to the function in TGF-b family signalling, Arkadia has been reported to ubiquitinate adaptor protein-2 m2 to enhance epidermal growth factor receptor signalling, suggesting possible involvement of Arkadia in the regulation of other signal transduction pathways (52, 53) . Recently, RNF111/Arkadia has been shown to be a SUMO-targeted ubiquitin ligase that facilitates the DNA damage response and/or involved in PML degradation (54, 55) . Interestingly, RNF111-dependent neddylation has been shown to activate DNA damage-induced ubiquitination (56) .
Other RING/U-box type E3 Ubiquitin Ligases
In addition to Arkadia, other RING type E3 ubiqutin ligases such as ROC1-SCF Fbw1a , SCF Skp2 complex and CHIP (carboxyl terminus of Hsc70-interacting protein), a U-Box-dependent E3 ligase, also mediate signalling by members of TGF-b family. The SCF complexes belong to multisubunit RING-type E3 ligase family, and participate in the degradation of various proteins. ROC1-SCF Fbw1a , containing ROC1/ Rbx1 (RING-finger protein), Cul1 (scaffold protein) and Skp1 (adaptor protein), binds to Smad3 (57) and Smad4 (58) to induce their degradation.
A RING-type E3 ubiquitin ligase complex SCF Skp2 has been shown to bind to Smad4 (59) . Interestingly, compared with wild-type Smad4, several cancerassociated mutants of Smad4 exhibit a significantly increased affinity for Skp2 that promotes the ubiquitination-dependent degradation of the mutant Smad4 (59). These results are consistent with previous reports in which some cancer-associated Smad4 mutants have been shown to exhibit accelerated induction of ubiquitin-dependent proteasomal degradation in comparison to wild-type Smad4 (60) . Skp2, which targets p27 for degradation, has also been reported to be up-regulated in various human cancers (61) . These results suggest that, the ubiquitination and degradation of cancerassociated mutants of Smad4 by the SCF Skp2 complex may be the molecular mechanism mediating both the oncogenic role of Skp2 and the tumour suppressor function of Smad4. The anaphase-promoting complex (APC) uses Smad3 as an adaptor for SnoN recruitment, resulting in the ubiquitin-dependent degradation of SnoN (62, 63) . SnoN degradation is an essential initial step in TGF-b signalling (64) . Therefore, the TGF-b-dependent degradation of SnoN, either through the Smurf2 pathway or the APC pathway, is thought to be required for activation of TGF-b signalling in a context-dependent manner.
A U-box-type E3 ligase, CHIP, has been shown to bind to Smad1 as well as Smad4 to regulate BMP signalling (65) . It has also been reported that CHIP interacts with Smad3 to negatively regulate TGF-b signalling (66). However, unlike ROC1/SCF Fbw1a , CHIP decreases total Smad3 levels in a TGF-b-independent fashion. CHIP may desensitize the cells to TGF-b by decreasing basal Smad3 levels.
Non-degradative Ubiquitination
In addition to degradative ubiquitination that induces proteasomal degradation of the target proteins, other types of ubiquitination, including mono-ubiquitination and K11/K63 chain-ubiquitination, do not induce proteasomal degradation and alter the activation state of target proteins such as subcellular localization and proteinprotein interactions.
Recently, various non-degradative ubiquitin modifications have been identified in TGF-b signalling pathway. Itch/atrophin-1 interacting protein 4 (AIP4) which has been shown to play a role in immune responses (67, 68), also mediate signalling by TGF-b. Bai et al. demonstrated that loss of Itch decreased susceptibility of growth inhibition and phosphorylation of Smad2 by TGF-b, without apparent alteration in Smad2/4/7 protein levels in ItchÀ/À mouse embryonic fibroblasts (MEFs) (69) . AIP4/Itch ubiquitinates Smad2 and increases phosphorylation of Smad2 to enhance TGF-b signalling. In contrast, it has been reported that Itch bind to Smad7 to block TGF-b signalling by enhancing the interaction between Smad7 and activated TbR-I without ligase activity (70) . Further studies will be needed to explain the precise molecular mechanism by which Itch regulate signalling by TGF-b.
Tripartite Motif protein 33 (TRIM33) (also known as Ectodermin/transcription intermediate factor 1g, TIF1g) is a RING-type E3 ubiquitin ligase that has been shown to be a negative regulator of Smad4 and a general inhibitor of TGF-b family signalling (7174). Indeed, Dupont et al. reported that TRIM33 poly-ubiquitinates and degrades Smad4 in overexpressing cells (71) , although this was later revised to TRIM33 mediating inhibitory mono-ubiquitylation of Smad4 at K519 in a histone-dependent manner, and this disrupts the interaction between Smad4 and phospho-Smad2/3 on the chromatin (72, 74) .
Tumour necrosis factor receptor (TNFR)-associated factor 6 (TRAF6) has been shown to act as an ubiquitin E3 ligase that preferentially conjugates K63 ubiquitin chains onto its target proteins. In TGF-b signalling pathway, TbR-I binds to TRAF6 and induces auto-ubiquitination and activation of TRAF6 after ligand stimulation. Activated TRAF6 binds to TGF-b-activating kinase (TAK1) and induces ubiquitination and activation of TAK1, which is important for the TGF-b-induced activation of the p38 MAP kinase pathway (75) . In cancer cells, upon TGF-b stimulation, TbR-I is ubiquitinated by TRAF6 and cleaved by TNFa-converting enzyme (TACE). The created intracellular domain of the receptor translocates to nucleus where it functions as a member of transcriptional complexes to induce the expression of EMT-related genes such as Snail and MMP2 (76) .
Deubiquitinating Enzymes
DUBs remove ubiquitin or ubiquitin chains from target proteins, thereby counteracting the function of E3 ligases. Deubiquitination by DUBs also plays a role in regulation of various biological processes. Several DUBs have been reported to regulate TGF-b signalling pathway. Ubiquitin C-terminal hydrolase UCH37 is a DUB that interacts with Smad7 and deubiquitinates TbR-I (77) (Fig. 3) . Thus, UCH37 stabilizes the type I receptor and acts as the counterpart of Smurfs in regulating expression of TbR-I. UCH37 has been also reported to enhance early signalling and play a role in TGF-b-induced migration (78) . The other DUB, USP15, has been shown to regulate TGF-b signalling by deubiquitinating mono-ubiquitinated R-Smads (79) (Fig. 3) . Because the mono-ubiquitinated R-Smads fail to bind DNA, USP15 is required for TGF-b-induced transcription by R-Smads. In glioblastoma, Eichhorn et al. showed that USP15 stabilizes TbR-I and promotes oncogenesis through the activation of TGF-b signalling (80) .
CYLD, associated molecule with the SH3 domain of SA (AMSH) and AMSH-like protein (AMSH-LP) are DUBs that preferentially hydrolyse or cleave K63-linked ubiquitin chains and regulate TGF-b signalling (81, 82) . CYLD is a tumour suppressor that acts as an inhibitor against JNK and NF-kB signalling, and has been shown to regulate TGF-b signalling in T cells (81) . CYLD inhibits the TGF-b-induced development of regulatory T cells through deubiquitination of Smad7 that inhibits the activation of TAK1 and p38.
AMSH and AMSH-LP have been reported to bind to I-Smads and inhibit their function to enhance TGFb and BMP signalling (83, 84). Although AMSH and AMSH-LP are DUBs that preferentially cleave K63-linked ubiqutin chains (82) , it remains unclear whether the DUB activity is necessary or not when AMSH and AMSH-LP affect on TGF-b signalling.
Mono-ubiquitination of Smad4 at K519 inhibits binding of Smad4 to phospho-Smad2. FAM/USP9x is a DUB that reverts this negative modification and re-empowers Smad4 function (72) (Fig. 3) . These findings support a new role for DUBs in the control of the TGF-b family signalling, and provide a novel molecular target for the design of inhibitors with therapeutic potential in various diseases.
Perspectives
Ubiquitination has been implicated in the regulation of TGF-b signalling via different mechanisms including the degradation of receptors, Smad proteins or their binding proteins. In addition, ubiquitin-dependent degradation of molecules in the non-Smad pathways, for example RhoA degradation through phosphorylation of Par6 (85), appears to be distinct and important aspect of relationship between ubiquitination and TGF-b signalling. Recently, various non-degradative ubiquitin modifications have been identified in TGFb signalling pathway. In addition to ubiquitination, deubiquitination has also been reported to regulate TGF-b family signalling. Moreover, TGF-b signalling also relies on ubiquitination for its effect on other pathways such as TRAF6 pathway. To note that TGF-b has been reported to induce and regulate autophagy and growth inhibition in certain cancer cells through the transcriptional activation of autophagy genes (86, 87) . The involvement of autophagy induction in the context of the TGF-b effects on the progression of cancers needs to be further studied. Disruption of ubiquitin modification systems that related to TGF-b family can lead to various diseases such as cancer. Further characterization of the regulatory mechanisms by ubiquitination as well as deubiquitination that relate to TGF-b family signalling will offer a molecular basis for diagnostic and therapeutic strategies based on ubiquitin modifications in TGFb-related diseases.
